[1]
Thach, T.H.T. et al. 2025. EVALUATION OF TREATMENT OUTCOMES AND ASSOCIATED FACTORS IN RECURRENT AND METASTATIC EPITHELIAL OVARIAN CANCER WITH CHEMOTHERAPY COMBINED WITH BEVACIZUMAB AT CAN THO ONCOLOGY HOSPITAL IN 2023 - 2025. Cantho Journal of Medicine and Pharmacy. 91 (Sep. 2025), 30–37. DOI:https://doi.org/10.58490/ctump.2025i91.3586.